The burden of anemia and RBC transfusions in the PICU population are significant. The current guidelines for pediatric blood transfusions are mainly based on available information regarding ...

Montreal, April 19th, 2007 -- In its April 19th, 2007 edition, the New England Journal of Medicine published an article about the findings of a multi-center randomized clinical trial that compared ...

The Transfusion Medicine/Hemostasis Clinical Trials Network (TMH CTN) was created by the National Heart, Lung, and Blood Institute (NHLBI) in 2002 and is charged with performing trials in children and ...

Noting the frequency of significant hemorrhage during craniofacial reconstruction surgery, and the importance of an adequate patient blood management (PBM) policy during such surgery, the researchers ...

Recently published research found that blood transfusion is associated with adverse outcomes -- including infection and higher rates of tumor recurrence -- in pediatric solid tumor oncology patients ...

Aurora: Blood transfusion is a critical and lifesaving intervention in a variety of situations, ranging from trauma response to cancer therapy. It is, however, not without risk. Recently published ...

Postsurgical bleeding causes significant morbidity and mortality in children undergoing surgery for congenital heart defects (CHD). 22q11.2 deletion syndrome (DS) is the second most common genetic ...

Neuroblastoma Mass Screening in Late Infancy: Insights Into the Biology of Neuroblastic Tumors Purpose: Severe anemias requiring RBC transfusions is a frequent complication of chemotherapy. A model ...

The Division of Clinical Pathology provides comprehensive, state-of-the-art, laboratory service across the full spectrum of diagnostic specialties. The Division performs over 16 million tests per year ...

Pediatr Health. 2010;4(2):201-208. For children with acute blood loss, maintaining an adequate intravascular volume (including by crystalloid and colloid infusions) is critical to ensure adequate ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Clinical Monitoring and Computing in which Dr. Ayten ...

Children Monitored with Masimo SpHb ® Had Less Blood Transfusion, Less Bleeding, and Shorter ICU Stays ...